Health
‘Two-tier’ health system denies public patient life-extending cancer drug
Imfinzi – which European Commission approved for treatment of bile duct cancer last year – has yet to be evaluated by NCPE
Imfinzi – which European Commission approved for treatment of bile duct cancer last year – has yet to be evaluated by NCPE